Gilead plans to go straight to Phase III studies for once-yearly lenacapavir, while GSK and Viiv will push forward with their ...

| Dr. Buzón discusses bridging science and reality, highlighting the vital role of real-world evidence in advancing HIV care ...

U=U is short for Undetectable = Untransmittable. It means that when a person living with HIV, adheres to effective ...

This year’s Conference on Retroviruses and Opportunistic Infections (CROI) features several sessions discussing prevention ...

The UK-based charity’s 'Not PrEPared' report uncovered that no local authority surveyed had more than five women receiving PrEP (the HIV prevention drug which reduces the risk of transmission).